Present and future roles of FDG-PET/CT imaging in the management of lung cancer

Abstract Integrated positron emission tomography/computed tomography (PET/CT) using 2-[18F]fluoro-2-deoxy-d-glucose (18F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluation in clinical oncologic imaging. This review discusses the utility of 18F-FDG PET/CT as a tool for managing patients with lung cancer. We discuss different patient management stages, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis.
Source: Japanese Journal of Radiology - Category: Radiology Source Type: research